Changes and Clinical Significance of PIVKA-II in Hepatitis E Patients

Chen, YR; Yang, YY; Li, SS; Lin, MH; Xie, XT; Shi, HF; Jiang, YC; Zheng, SJ; Shao, H; Yang, NB; Lu, MQ

Lu, MQ (通讯作者),Wenzhou Med Univ, Dept Infect Dis, Affiliated Hosp 1, Wenzhou, Peoples R China.;Yang, NB (通讯作者),Ningbo First Hosp, Dept Infect Dis, Ningbo, Peoples R China.

FRONTIERS IN PUBLIC HEALTH, 2022; 9 ():

Abstract

Increased protein induced by vitamin K absence or antagonist-II (PIVKA-II) levels had been widely reported in patients with hepatocellular carcinoma (......

Full Text Link